New Study Will Evaluate Electroacupuncture for NMOSD
Patients With NMOSD May Have Cognitive Impairment
Study Finds Brain Changes Specific to MS and NMOSD
Off-Label Monoclonal Antibodies May Be Safe and Effective in Treating NMOSD
More Pathogenic Factors Must Be Found in NMOSD, Study Says
New Biospecimen Collection Program Could Speed Development of New NMOSD Treatments
Granulocyte Activation Markers Could Distinguish NMOSD From MS
Tailored Rituximab Treatment May Be Beneficial for NMOSD and MOGAD
Preventing Relapses May Increase the Number of Patients With Benign NMOSD
TACs Could Be the Only Initial Brainstem Manifestation of NMOSD
NMOSD Clinical Trials
Assessing Existing NMOSD Therapeutic Strategies
There are a number of therapeutic strategies available for treating NMOSD, although as a whole they are largely inadequate.
Tackling Misdiagnosis in NMOSD
Around a quarter of NMOSD cases are initially misdiagnosed, leading to potentially devastating consequences.
Rare Case of MS Followed By NMOSD Reported
A 57-year-old female with stable multiple sclerosis suddenly presented with symptoms of neuromyelitis optica spectrum disorder.
How NMOSD May Impact Pregnancy and Fertility
Studies have attempted to shed light on the risk factors associated with a pregnancy-related NMOSD attack.
The Emotional Response to a NMOSD Diagnosis Explored
Studies reveal that patients often describe feelings of shock, confusion, and sadness upon a diagnosis of NMOSD.
When NMOSD and Sjögren Syndrome Intersect
Scientists have observed that patients who have comorbidities such as Sjögren syndrome (SjS) have a more severe presentation of NMOSD.
My Rare Disease Journey: Being Strong Is the Only Option
Since being diagnosed with neuromyelitis optical spectrum disorder (NMOSD), finding the strength to move forward is what defines my life.
To My Fellow Rare Disease Patients: Celebrate Small Victories
Having a rare disease like neuromyelitis spectrum disorder (NMOSD) can make you feel hopeless at times.
Omidubicel Shows Promise as Replacement for Umbilical Cord Blood in Stem Cell Transplants
Gamida Cell is gearing up to begin sales of omidubicel from Israel to US hospitals for use in stem cell transplants, pending FDA approval of the therapy.
Ambitious NCATS Bespoke Gene Therapy Consortium Targets Ultrarare Diseases
The Bespoke Gene Therapy Consortium (BGTC) is an ambitious public-private partnership that aims to develop gene therapies for ultrarare diseases.
International Sumaira Foundation Aims to Stop Frequent Misdiagnosis of NMOSD
Sumaira Ahmed, an advocate for patients with NMOSD, is featured in an episode of PBS-TV’s award-winning documentary series Medical Stories.
Boston-Based Neurologist Michael Levy Leads Research on Treating NMOSD
Michael Levy, MD, PhD, director of the Neuroimmunology and Neuro-Infectious Diseases Division of Massachusetts General Hospital, is an expert on NMOSD.
Rare Care Podcast